Filing Details

Accession Number:
0001209191-23-030141
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-17 16:07:38
Reporting Period:
2023-05-15
Accepted Time:
2023-05-17 16:07:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1396814 Pacira Biosciences Inc. PCRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1309702 J Paul Hastings C/O Pacira Biosciences, Inc.
5401 West Kennedy Boulevard, Suite 890
Tampa FL 33609
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-05-15 7,000 $29.90 14,179 No 4 M Direct
Common Stock Disposition 2023-05-15 7,000 $41.85 7,179 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2023-05-15 7,000 $0.00 7,000 $29.90
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2023-06-12 No 4 M Direct
Footnotes
  1. The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
  2. The stock option vested and became exercisable in twelve equal monthly installments, with the first installment being on July 12, 2013.